Rhumbline Advisers »

Mineralys Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $291k 23k 12.91
2023-12-31 $176k 21k 8.60
2023-09-30 $163k 17k 9.51
2023-06-30 $254k 15k 17.05
2023-03-31 $172k 11k 15.69